BERLIN — More very encouraging data on the use of autologous stem cell transplant in multiple sclerosis (MS) have been presented. There was no evidence of disease activity post transplant in patients ...

U.S. regulators have approved the first drug for an aggressive kind of multiple sclerosis that steadily reduces coordination and the ability to walk. The Food and Drug Administration approved Ocrevus ...